Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
| Image |  |
|---|---|
| Description | scientific article published on 24 February 2004 |
| Author/s |
author: Michael Pfreundschuh |
| Publication date | February 24, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |